Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.87 HKD | +1.18% | -3.78% | +2.99% |
04-15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
04-15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
MarketScreener Editorial Features
Global markets live: WM Morrison, IBM, Didi... | July 05, 2021 at 10:38 am |
- Stock Market
- Equities
- 1477 Stock
- News Ocumension Therapeutics
- MarketScreener Editorial Features